Generic drug
Methylphenidate price, strengths & recalls
Generic of Ritalin, Concerta, Relexxii, Jornay, Cotempla
Pharmacies pay $5.98 for 30 tablets of Methylphenidate 20 mg tablet this week, and from $3.65 to $570.00 across its 36 priced strengths and forms. 28 manufacturers make it. It is in shortage (unavailable). 1 recall is ongoing. Its official label last changed on June 3, 2026.
Unavailable1 open recallGeneric- Fair cash price
- $17.38
- Strengths
- 36
- Makers
- 28
- Updated
- Nov 11
Methylphenidate price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
The lowest cost per tablet is 5 mg tablet at $0.1218. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.
Brand names of methylphenidate
A brand and its generic share the active ingredient; the generic is almost always far cheaper.
Supply status: shortages & recalls
Shortages
- Relexxii, Tablet, Extended Release, 45 mg (NDC 68025-088-30)
- Methylphenidate Hydrochloride, Tablet, Extended Release, 72 mg (NDC 13811-710-30)Allocation to current contracted customers
- Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-30)
- Relexxii, Tablet, Extended Release, 72 mg (NDC 68025-084-30)
- Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-10)Temporary discontinuation of 100ct
- Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-30)
- Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-10)Temporary discontinuation of 100ct
- Methylphenidate Hydrochloride, Tablet, Extended Release, 63 mg (NDC 13811-700-30)Allocation to current contracted customers
- Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 13811-706-10)Allocation to current contracted customers
- Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-10)
- Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 13811-709-10)Allocation to current contracted customers
- Concerta, Tablet, Extended Release, 18 mg (NDC 50458-585-01)
In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.
Recalls
Showing the 6 most relevant of 66 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Methylphenidate
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES.METHYLPHENIDATE HYDROCHLORIDE extended-release capsules, for oral use, CIIInitial U.S. Approval: 1955
WARNING: ABUSE, MISUSE, AND ADDICTION
Methylphenidate hydrochloride extended-release has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including methylphenidate hydrochloride extended-release, can result in overdose and death [see Overdosage (10)], and this risk is increased with higher doses or unapproved methods of administration, such as snorting or injection.
Before prescribing methylphenidate hydrochloride extended-release, assess each patient's risk for abuse, misuse, and addiction. Educate patients and their families about these risks, proper storage of the drug, and proper disposal of any unused drug. Throughout methylphenidate hydrochloride extended-release treatment, reassess each patient's risk of abuse, misuse, and addiction and frequently monitor for signs and symptoms of abuse, misuse, and addiction [see Warnings and Precautions (5.1) and Drug Abuse and Dependence (9.2)].
WARNING: ABUSE, MISUSE, AND ADDICTION
See full prescribing information for complete boxed warning.
Methylphenidate hydrochloride extended-release has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including methylphenidate hydrochloride extended-release, can result in overdose and death (5.1, 9.2, 10):
Before prescribing methylphenidate hydrochloride extended-release, assess each patient's risk for abuse, misuse, and addiction.
Educate patients and their families about these risks, proper storage of the drug, and proper disposal of any unused drug.
Throughout treatment, reassess each patient's risk and frequently monitor for signs and symptoms of abuse, misuse, and addiction.
Recent major changes (as listed on the label)
RECENT MAJOR CHANGES
Indications and Usage (1) 09/2025
Warnings and Precautions (5.7) 09/2025
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA021284 · Sandoz
- First approved
- June 5, 2002 (24 years ago)
- Latest approved change
- September 23, 2025
- Approved label
- PDF, Sep 25, 2025
- Generic makers
- 31 approved generic applications on the market
Methylphenidate questions
How much does methylphenidate cost without insurance?
Pharmacies pay about $5.98 for 30 tablets of methylphenidate 20 mg tablet ($0.1993 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $17.38. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
What is the brand name of methylphenidate?
Is methylphenidate in shortage?
Yes. 38 products are listed as in shortage or being discontinued (unavailable). See which ones.
Has methylphenidate been recalled?
66 recalls on record, 1 ongoing. Recalls name specific lots - check yours.
When did the methylphenidate label last change?
The official label was last updated on June 3, 2026 (version 11). See what changed.
Talk about methylphenidate
No comments yet. Questions, tips, what worked for you - start the conversation.